Xlife Sciences AG Total Liabilities

Latest as of December 2025: CHF144.76 Million CHF ≈ $183.01 Million USD

Xlife Sciences AG total liabilities. Based on the latest financial reports, Xlife Sciences AG (XLS) has total liabilities worth CHF144.76 Million CHF (≈ $183.01 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Xlife Sciences AG to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Xlife Sciences AG (2019–2025)

Total liabilities of Xlife Sciences AG from 2019 to 2025. This chart illustrates how Xlife Sciences AG's total liabilities have evolved over time, based on quarterly financial data.

Xlife Sciences AG Competitors by Total Liabilities

The table below lists competitors of Xlife Sciences AG ranked by their total liabilities.

Company	Country	Total Liabilities
Ekadharma International Tbk JK:EKAD	Indonesia	Rp113.92 Billion
ADVENICA AB F:65R	Germany	€93.48 Million
Duran-Dogan Basim ve Ambalaj Sanayi AS IS:DURDO	Turkey	TL1.36 Billion
Hoffmann Green Cement Technologies PA:ALHGR	France	€44.23 Million
Airship AI Holdings Inc NASDAQ:AISP	USA	$26.37 Billion
Export Packing KO:002200	Korea	₩59.07 Billion
North European Oil Royalty Trust NYSE:NRT	USA	$2.02 Million
Bound and Beyond PCL BK:BEYOND	Thailand	฿6.57 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Xlife Sciences AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Xlife Sciences AG's balance sheet.

Liquidity & Leverage Metrics

Xlife Sciences AG Total Liabilities Ratios Explained

Xlife Sciences AG total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.10	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.51	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Xlife Sciences AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Xlife Sciences AG (2019–2025)

The table below shows the annual total liabilities of Xlife Sciences AG from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	CHF144.76 Million ≈ $183.01 Million	-38.43%
2024-12-31	CHF235.11 Million ≈ $297.25 Million	-3.57%
2023-12-31	CHF243.82 Million ≈ $308.25 Million	-4.38%
2022-12-31	CHF255.00 Million ≈ $322.38 Million	-5.15%
2021-12-31	CHF268.83 Million ≈ $339.87 Million	+384.27%
2020-12-31	CHF55.51 Million ≈ $70.18 Million	-2.00%
2019-12-31	CHF56.64 Million ≈ $71.61 Million	--

About Xlife Sciences AG

SW:XLS Switzerland Biotechnology

Market Cap

$63.73 Million

CHF50.41 Million CHF

Market Cap Rank

#20790 Global

#197 in Switzerland

Share Price

CHF8.74

Change (1 day)

+0.92%

52-Week Range

CHF8.50 - CHF26.00

All Time High

CHF52.00